ATYR
Atyr Pharma Inc
$0.79+0.00 (0.00%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
aTYR PHARMA INC (ATYR) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 11 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-09 | 2026-01-09 | Broadfoot Jill Marie | CFO | Award | 412,500 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-09 | Shukla Sanjay | CEO | Award | 1,500,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-09 | Denyes Nancy | General Counsel | Award | 412,500 | $0.00 | $0 | N/A | N/A |
| 2025-10-09 | 2025-10-09 | Schimmel Paul | Director | Purchase | 317,999 | $0.94 | $299,237 | +6.3% | -12.9% |
| 2025-10-09 | 2025-10-08 | Schimmel Paul | Director | Purchase | 682,001 | $0.90 | $612,437 | +13.6% | -8.7% |
| 2025-05-02 | 2025-05-01 | Gross Jane A | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-02 | 2025-05-01 | Schimmel Paul | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-02 | 2025-05-01 | Zaknoen Sara | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-02 | 2025-05-01 | Coughlin Timothy | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-02 | 2025-05-01 | Lucas Svetlana | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.